{
  "main_header": {
    "sid": 10040119,
    "name": "Symbiotec Pharma",
    "stock_name": "Symbiotec Pharma",
    "full_name": "Symbiotec Pharmalab Ltd",
    "name_url": "stocks-analysis/symbiotec-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,087.85",
    "chg": -6.5,
    "chgp": "-0.59%",
    "dir": -1,
    "prev_price": "1,094.35",
    "mcapval": "6,957.00 Cr",
    "mcap": "",
    "scripcode": 544889,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE899I01028",
    "curr_date": "Oct 09",
    "curr_time": "",
    "bse_nse_vol": 35667,
    "exc_status": "Active",
    "traded_date": "Oct 09, 2026",
    "traded_date_str": "2026 10 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/symbiotec-pharma-10040119-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "10040119",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/symbiotec-pharmalab-10040119"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Oct-2026",
      "details": "Certificate Pursuant to regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended September 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Symbiotecs Wholly Owned Subsidiary Knovea Pharmaceutical Enters Into Strategic Commercialization Agreement With A Leading Global Pharmaceutical Company For Dual Chamber Vial Products In The U.S.",
      "datetime": "30-Sep-2026",
      "details": "Symbiotecs Wholly Owned Subsidiary Knovea Pharmaceutical enters into strategic commercialization agreement with a leading global pharmaceutical company for Dual Chamber Vial (DCV) products in the U.S.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "29-Sep-2026",
      "details": "Intimation of Closure of Trading Window for the second quarter of FY 2026-27.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News